Fiduciary Trust Co Grows Position in UnitedHealth Group Incorporated (NYSE:UNH)

Fiduciary Trust Co raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 69,828 shares of the healthcare conglomerate’s stock after purchasing an additional 738 shares during the quarter. Fiduciary Trust Co’s holdings in UnitedHealth Group were worth $35,323,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of UNH. Sugarloaf Wealth Management LLC boosted its holdings in shares of UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after purchasing an additional 1,193 shares during the period. Signal Advisors Wealth LLC grew its holdings in UnitedHealth Group by 13.0% during the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after purchasing an additional 1,051 shares during the last quarter. Waycross Partners LLC boosted its position in shares of UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock valued at $14,060,000 after buying an additional 658 shares during the period. Czech National Bank raised its holdings in shares of UnitedHealth Group by 6.1% in the fourth quarter. Czech National Bank now owns 199,536 shares of the healthcare conglomerate’s stock worth $100,937,000 after buying an additional 11,426 shares during the period. Finally, Lmcg Investments LLC grew its position in UnitedHealth Group by 11.8% in the 4th quarter. Lmcg Investments LLC now owns 37,974 shares of the healthcare conglomerate’s stock valued at $19,210,000 after acquiring an additional 4,022 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $385.74 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52 week low of $385.37 and a 52 week high of $630.73. The business’s 50 day moving average price is $489.89 and its 200 day moving average price is $523.90. The firm has a market cap of $351.11 billion, a P/E ratio of 24.89, a P/E/G ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same period in the previous year, the company posted $6.91 earnings per share. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 2.18%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.18%.

Analysts Set New Price Targets

A number of research analysts have recently commented on the stock. Oppenheimer cut their price target on shares of UnitedHealth Group from $640.00 to $600.00 and set an “outperform” rating on the stock in a report on Monday, April 21st. Wells Fargo & Company dropped their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 28th. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 22nd. Barclays lowered their price objective on shares of UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating for the company in a research note on Monday, April 21st. Finally, Truist Financial reduced their price target on shares of UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating for the company in a report on Monday, April 21st. Four analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus target price of $596.86.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.